SLGCW

SomaLogic, Inc. Warrant
SLGCW

Delisted

SLGCW was delisted on the 5th of January, 2024.

Back to rankings
 

About: SomaLogic is a commercial-stage proteomics company. It operates as a protein biomarker discovery and clinical diagnostics company that develops slow off-rate modified aptamers, which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. The Somamers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development.

Employees: 451

Healthcare Diagnostics & Research
Charts implemented using Lightweight Charts™